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A B S T R A C T
Migraine is one of the most prevalent types of headache, which imposes a substantial
burden on society as measured by direct and indirect costs. In the present work we re-
view the obstacles to carrying out migraine epidemiological studies. Knowledge of the
epidemiology of migraine has expanded because of the recent proliferation of large scale
population-based studies using standardized case definitions. Previous surveys of the
prevalence of migraine have given widely differing results. Even in population-based
studies, there have been wide variations in estimates of migraine prevalence. The devel-
opment of International Headache Society (IHS) criteria for migraine has facilitated in-
ternational comparisons in epidemiologic studies by providing explicit and consistent
diagnostic criteria, Recent studies using IHS diagnostic criteria have given relatively
consistent estimates of migraine prevalence (about 15–18% of women and 6% of men).
Studies of racial diversity in the prevalence of migraine and other headaches are still
not conclusive. Further work is needed on epidemiology of migraine and collaboration
between epidemiologists and clinicians seems the most likely way to advance under-
standing in this field.
Introduction
Headaches are traditionally classified
into two major groups: primary and sec-
ondary disorders1–11. Primary headaches
are mainly divided into migraine, ten-
sion-type headache, and cluster head-
ache6,11.
Several factors have complicated the
classification of headache, including the
continuing debate as to whether tension-
type headache and migraine are distinct
categories of disease or rather share a
common pathophysiology, differing more
in degree of severity than in kind5,10,12.
From a public health perspective, mi-
graine and tension-type headache are the
two most important primary headache
disorders because of their high preva-
lence and the associated disability. De-
spite the fact that headache is one of the
most frequently reported symptoms in
the adult general population, little is
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known about the epidemiology of the
headache disorders. The major problem
has been that of defining the disease enti-
ties, since no laboratory correlate or other
objective defining marker exists.
Migraine is one of the most prevalent
types of headache. In addition, it consti-
tutes a pathology which due to its cyclic,
recurring and highly incapacitating char-
acteristics has enormous repercussions
on the quality of life of those affected; it is
responsible for the loss of an important
number of working days and of produc-
tion; responsible too for the vast consump-
tion of medicaments and consequently
represents a considerable economic cost.
An epidemiological study of migraine,
however, poses countless difficulties ow-
ing to its characteristics and its associa-
tion with risk factors. In this present pa-
per we review the obstacles to carrying
out migraine epidemiological studies and
we also comment upon many such studies
found in the literature.
Importance of migraine epidemiology
studies
There are a number of reasons to stu-
dy the epidemiology of migraine:
• First, epidemiologic methods can be
used to assess the reliability and valid-
ity of various case definitions13,14 and –
also – to improve the case-definitions
used in clinical practice and research;
• Studies of migraine prevalence provide
one measure of the scope of the head-
ache problem;
• Consequently, epidemiologic methods
can be used to assess the impact of mi-
graine on individuals and society;
• Epidemiologic methods can clarify the
relationship of migraine to other pri-
mary headache disorders4,5,6;
• Examination of sociodemographic, ge-
netic and environmental risk factors
help us to identify groups at highest
risk for some kinds of migraine head-
aches, which may provide clues to
preventive strategies or clues to dis-
ease mechanisms.
• Epidemiology methods are useful to de-
termine the natural history of migraine
including health consequences and
co-morbid conditions.
• Last, but not the least, epidemiology
may help us to assess current patterns
of diagnosis and treatment of migraine
as a prelude to public health interven-
tions.
Methodological Problems
There are several methodological
problems related to the study of the epi-
demiology of migraine. At the beginning,
we have problems of defining disease en-
tities. Perhaps most importantly, there is
no biological test to ensure definitive di-
agnosis of the primary headache disor-
ders, including migraine10.
Diagnosis of migraine is, therefore,
based on clinical assessment, which is
complicated by some factors:
• The episodic nature of migraine, which
necessitates reliance on patients' recol-
lections of symptoms.
• The poor demarcation among the pri-
mary headache disorders; we are often
faced with the fact that patients often
have more than one type of headache2.
• Problems connected with the composi-
tion and representativeness of the
study population.
The development of International
Headache Society (IHS) criteria for pri-
mary headaches has facilitated interna-
tional comparisons in epidemiologic stud-
ies by providing – we believe – explicit
and consistent diagnostic criteria11.
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Controversies in Epidemiology of
Migraine
Now, let’s try to answer the question:
How common is migraine?
Most epidemiologic studies of mi-
graine have emphasized disease preva-
lence. Prevalence is the proportion of a
given population, which has migraine
over a defined period of time. Lifetime
prevalence of migraine refers to the pro-
portion of individuals who have ever had
the condition. Period prevalence refers to
the proportion of individuals who have
had at least one migraine attack within
some defined interval, usually within 1
week, 4 weeks, 3 months, or one year of
the time of ascertainment. Prevalence in-
creases as the period selected for study
increases.
Migraine epidemiology has been stud-
ied extensively in the United States,
Great Britain, and Western Europe,
while this type of study is very rare in de-
veloping countries. Using the IHS crite-
ria, large population-based epidemiologi-
cal studies in Denmark, the United
States, France, Germany and elsewhere
have shed light on the descriptive epide-
miology of migraine. According to most
famous names in the field of headache ep-
idemiology – Rasmussen, Lipton and
Stewart – the one-year prevalence of mi-
graine in Western countries is approxi-
mately 6% among men and 15% to 17.6 %
among women3,7.
Prevalence varies by age, increasing
to about age 40 years and declining there-
after in both men and women. Migraine
occurs across all age groups, but the most
commonly affected are those in the so-
called »earning« years (25 to 44 years of
age), the time of maximum employment
and productivity. The gender ratio also
appears to vary by age, increasing from
menarche to about age 42 years and de-
clining thereafter. The majority of mi-
graine sufferers do not regularly seek
medical help. Although only a small per-
centage of migraine sufferers actually
seek care at any given time, about 85% of
females and 77% of males sought medical
attention at some point for migraine. 8%
of migraineurs were hospitalized for the
disorder3,7.
On the other hand, we must admit
that other, numerous surveys of the prev-
alence of migraine headache have given
widely differing, indeed often conflicting
results.
For example, estimates of migraine
prevalence in different countries of Eu-
rope vary from less than 5% to more than
a quarter of the total population. (Table
1)8,15–22. There are a number of possible
reasons for these differences.
Perhaps the most unlikely is that the
published findings represent real differ-
ences in the prevalence of migraine in the
populations studied. More likely, in our
present state of knowledge, they repre-
sent methodological differences between
the various surveys and differences in the
diagnostic criteria. The meta-analysis of
24 population-based headache prevalence
studies, made by Stewart, showed that
70% of the variation in estimated preva-
lence of migraine is accounted for by dif-
ferences in the definitions of migraine, as
well as the age and gender distribution of
the study samples23. In particular, the
studies which included »warning sings«
of migraine as diagnostic criteria tended
to give the highest prevalence estima-
tes24.
Most migraine epidemiology studies
have involved small numbers of subjects,
specific age groups, limited geographical
areas, or study samples chosen from spe-
ciality clinics, outpatient practices, or ter-
tiary care centers2,3,25.
Not all of those suffering with mi-
graine seek medical attention7,10,26. The-
refore, some groups may be under repre-
sented in studies of patients consulting
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physicians for treatment of migraine. Per-
sons with low income, individuals with
headache that responds to over-the-coun-
ter analgesics, those who experience no
disability, and those who perceive their
headache to be of mild-to-moderate inten-
sity or of short duration are most likely to
be overlooked4.
The same pattern as in European
countries – obviously differing data – we
have in epidemiologic studies of primary
headaches outside Europe. For example,
we present data of migraine one-year
prevalence from both Americas and Asia
(Table 2)7,27–33. Except the first one (this
study was included because of the huge
representative sample), they were also
conducted according to IHS criteria.
Which explanation we could offer here?
International variation in migraine
prevalence could result from methodolog-
ical differences among studies, cultural
differences in symptom reporting, varia-
tion in environmental risk factors, or
race-related differences in genetic sus-
ceptibility to migraine. The available evi-
dence supports a possible role for both en-
vironmental and genetic risk fac-
tors21,34,35.
Comparative studies in different ra-
ces, or different geographical areas, have
yielded important insights into risk fac-
tors for other diseases. For example, the
role of cholesterol as a risk factor for myo-
cardial infarction was discovered, in part,
because of international differences in
the prevalence of heart disease. Applica-
tion of this strategy to migraine requires
that we search for variation in migraine
prevalence across various definable
groups and then identify the genetic or
environmental factors which account for
the variation.
Epidemiologic studies show that ten-
sion-type headache is 2 to 6 times more
likely than migraine, but there are also
significant variations in estimated preva-
lence of these kind of headache36–38. The
same problem we have in prevalence of
cluster headache, too39,40.
Because the prevalence of migraine
appears to be increasing, especially in
those under 45 years of age, additional
societal costs due to lost productivity and
increased utilization of health care ser-
vices can be expected. Because it is un-
clear what proportion of migraine suffer-
ers seek medical attention for their
headache, more rigorous detection is nec-
essary to adequately study the full im-
pact of this disease.
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TABLE 1
ONE-YEAR PREVALENCE OF MIGRAINE IN SOME EUROPEAN COUNTRIES. DATA ARE







France (1993)15 1,563 4.27 6 1.7
Finland (1993)16 22,809 6.3 10.1 2.5
France (1992)8 4,204 8.1 11.9 4.0
Portugal (1995)17 2,008 8.8 – –
Norway (1992)18 230 11.7 13.8 5.4
Denmark (1995)19 740 – 15 6
Denmark (1992)20 1,000 – 15.3 5.9
Netherlands (1999)21 6,491 – 25 7.5
Germany (1994)22 4,061 27.5 32 22
To obtain accurate estimates of mi-
graine headache prevalence, population-
based studies are required. Clinic-based
studies include a highly selected group of
migraine sufferers. Population based stu-
dies examine sufferers whether or not
they consult doctors by actively identify-
ing migraine symptoms in representative
samples. For example, most migraine
studies are clinic based, yet less than 15%
of migraine sufferers ever consult neurol-
ogists, and less than 2% consult headache
specialists. This can result in substantial
selection bias19,41,42.
As it was shown earlier, even in popu-
lation-based studies there have been
wide variations in estimates of migraine
prevalence. Although the use of the IHS
criteria has resulted in a more coherent
picture across population-based studies,
efforts must be made to assess the reli-
ability and validity of these criteria in
population-based samples.
In theory, aggregation of data from
multiple trials should enhance the preci-
sion and accuracy of any pooled result.
But combining data requires a leap of
faith: it presumes that the differences
among studies are primarily due to
chance. In fact, differences in the direc-
tion or size of treatment effects may be
caused by other factors, including subtle
differences in treatments, populations,
outcome measures, study design, and stu-
dy quality. Thus meta-analyses may
generate misleading results by ignoring
meaningful heterogeneity among studies,
entrenching the biases in individual stu-
dies, and introducing further biases
through the process of finding studies
and selecting results to be pooled43.
In sum, meta-analysis has made and
continues to make major contributions to
medical research, clinical decision mak-
ing, and standards of research reportage.
However, it is no panacea. Readers need
to examine any meta-analyses critically
to see whether researchers have over-
looked important sources of clinical het-
erogeneity among the included trials.
They should demand evidence that the
authors undertook a comprehensive
search, avoiding covert duplicate data
and unearthing unpublished trials and
data. Lastly, readers and researchers
alike need to appreciate that not every
systematic review should lead to an ac-
tual meta-analysis of data with aggregate
effect size estimates. If the process of
pooling data inadvertently drowns clini-
cally important evidence from individual
studies, then a meta-analysis can do
more harms than good.
At last, something about using the
questionnaires in migraine epidemiology
studies. Many of the epidemiological
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TABLE 2







China (1988)27 246,812 0.69 1.13 0.24
USA (1989)28 20,000 4.1 5.77 2.32
USA (1992)7 20,468 – 17.6 5.7
Japan (1993)29 5,477 3.5 5.2 1.8
Japan (1997)30 4,029 6 13 3.6
Malaysia (1996)31 595 9 11.3 6.7
Chile (1997)32 1,540 7.3 11.9 2.0
China (1997)33 1,533 3 – –
studies on the prevalence of headaches in
the general population of children have
used more or less standardized question-
naires1–7. Given the variety of instru-
ments and classifications, it is not sur-
prising that these investigations mention
a variety of prevalences for migraine
headaches. A difficulty in investigating
all kinds of primary headaches with ques-
tionnaires is that many individuals suffer
from both typical migraine and non-mi-
grainous headaches. A possible source of
bias is the different responses that result
from the use of a questionnaire in differ-
ent situations. Obviously, the actual
wording of the questions is also impor-
tant. Further, the diagnosis is very often
made by incompetent person44.
Studies of observer variation in medi-
cine often show wide discrepancies but
few such studies have been concerned
with migraine. Such studies are needed
and should be carefully designed and con-
ducted.
Conclusions
More documentation of the age at on-
set, symptoms, frequency of attacks, and
other characteristics related to migraine
would be very useful to compare properly
results between studies. We need addi-
tional descriptive epidemiologic studies
of migraine, which would include reliable
estimates of age-specific incidence, preva-
lence, remission rates, and natural his-
tory of the various migraine subtypes.
Further work is needed on epidemiology
of primary headaches and collaboration
between epidemiologists and clinicians
seems the most likely way to advance un-
derstanding in this field.
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POPULACIJSKE VARIJACIJE U PREVALENCIJI MIGRENE:
NERIJE[ENI PROBLEM
S A @ E T A K
Migrena predstavlja jedan od naju~estalijih tipova glavobolje, te kroz neposredne i
posredne tro{kove koje izaziva predstavlja zna~ajno optere}enje za {iru dru{tvenu za-
jednicu. U izlo`enom su osvrtu predo~ene zapreke na koje nailazimo u provo|enju epi-
demiolo{kih istra`ivanja migrene. Posljednjih su godina spoznaje o epidemiologiji
migrene pro{irene brojnim populacijskim istra`ivanjima, pri ~emu su kori{tene stan-
dardizirane definicije podtipova sindroma glavobolje. Ranija su istra`ivanja prevalen-
cije migrene rezultirala, uglavnom, vrlo neujedna~enim rezultatima. ^ak su i u po-
pulacijskim istra`ivanjima postojale izrazite razlike u procjeni prevalencije migrene.
Uspostavljanje tzv. IHS (International Headache Society) kriterija za dijagnozu
migrene omogu}ilo je usporedbu rezultata epidemiolo{kih istra`ivanja u raznim dije-
lovima svijeta, jer su njihovim prihva}anjem dijagnosti~ki kriteriji bili usugla{eni i
op}enito razumljiviji. Novija epidemiolo{ka istra`ivanja temeljena na spomenutim
IHS kriterijima rezultirala su uglavnom sli~nim procjenama prevalencije migrene (oko
15-18% `ena i 6% mu{karaca). Me|utim, istra`ivanja populacijskih razlika u preva-
lenciji migrene i drugih tipova glavobolje jo{ uvijek daju vrlo neujedna~ene rezultate.
Stoga se name}e potreba za daljnjim naporima na unaprje|ivanju metodologija u
istra`ivanju epidemiologije migrene. Suradnja epidemiologa i klini~ara je vjerojatno je
najispravniji put prema unaprje|ivanju spoznaja na tom podru~ju.
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